Handelsinvest - opdatering af forventede udbytter for regnskabsåret 2022
Investeringsforeningen Handelsinvest Østergade 2 7400 Herning Tlf. 9712 3355 info@handelsinvest.dk www.handelsinvest.dk | |
Nasdaq Copenhagen A/S Nikolaj Plads 6 1007 København K | |
| 19. januar 2023 |
Opdatering af forventede udbytter for regnskabsåret 2022
I forlængelse af selskabsmeddelelse af 18. november 2022 og 5. januar 2023 offentliggøres de opdaterede udbytter for regnskabsåret 2022 her:
| UDBYTTER NOTEREDE FONDE | ||
| Afdeling | ISIN | Udbytte pr. andel |
| Danske Obligationer | DK0060040087 | 0,40 kr. |
| Virksomhedsobligationer | DK0060262061 | 0,00 kr. |
| Højrentelande | DK0060014918 | 0,00 kr. |
| High Yield Bonds | DK0061406964 | 0,00 kr. |
| Verden | DK0010157296 | 7,60 kr. |
| Europa | DK0015809065 | 0,00 kr. |
| Nordamerika | DK0060159218 | 4,80 kr. |
| Fjernøsten | DK0015994453 | 7,90 kr. |
| Norden | DK0060048064 | 0,00 kr. |
| Danmark | DK0010232768 | 27,60 kr. |
| Handelsinvest Defensiv 10 | DK0060774479 | 0,00 kr. |
| Handelsinvest Defensiv 30 | DK0060774552 | 0,00 kr. |
| Handelsinvest Offensiv 60 | DK0060774636 | 2,10 kr. |
| Handelsinvest Offensiv 80 | DK0060774719 | 1,10 kr. |
Sidste dag for handel med de enkelte afdelinger inklusive ret til aconto-udbytte er den 23. januar 2023 og første dag for handel med de enkelte afdelinger eksklusiv ret til aconto-udbytte er den 24. januar 2023.
Udbyttet indsættes på investorernes konti den 26. januar 2023.
Satserne er foreløbige og kan således ændre sig indtil det endelige regnskab foreligger og er vedtaget på foreningens generalforsamling i foråret 2022.
Yderligere oplysninger kan fås ved henvendelse til Managing director Henrik Kragh, tlf. nr. 9992 0130.
For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.
Information om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeddelelser fra GlobeNewswire by notified
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra GlobeNewswire by notified
Bombardier CEO Éric Martel Evolves Leadership Team Structure as Part of Forward-Looking Growth Strategy, Building on Company Momentum6.2.2023 13:58:00 CET | Press release
Jean-Christophe Gallagher appointed Executive Vice President, Aircraft Sales and Bombardier Defense Paul Sislian appointed Executive Vice President of Bombardier Aftermarket Services & StrategyDavid Murray appointed Executive Vice President, Manufacturing, IT and Bombardier Operational Excellence SystemEric Filion joins Bombardier to the newly created role of Executive Vice President, Programs and Supply ChainMichel Ouellette will lead Engineering and Product Development until planned retirement later in 2023, following a 33-year, successful career MONTREAL, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Bombardier today announced a leadership team evolution that will focus on carrying forward the company’s positive momentum toward executing long-term growth and optimization strategies in the key areas of defense, services, continuous product improvement and next-generation manufacturing practices. “Bombardier has successfully embarked on its journey as a company focused on its world-class business
Vision Energy Concludes Jetty Simulation Study6.2.2023 13:30:00 CET | Press release
JERSEY CITY, N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Vision Energy Corporation (OTCPINK:VENG) (“Vision Energy” or the “Company”) is pleased to announce it has concluded a detailed marine simulation study for the proposed design and future operations of jetty and quay wall infrastructure that will serve its Green Energy Hub in North Sea Port of Vlissingen, the Netherlands. The Company’s wholly owned subsidiary, Evolution Terminals BV, engaged Maritime Research Institute Netherlands (“MARIN”) to carry out the study, in cooperation with North Sea Port authority. MARIN is an internationally operating and recognised leading independent institution for maritime research with over 400 specialists, with headquarters in Wageningen, the Netherlands. MARIN strives for clean, smart and safe shipping and sustainable use of the sea and is an independent knowledge partner for the maritime sector, government and society. The purpose of the study was to determine whether arrival and departure maneuvers
Freshworks and Meta Partner to Help Businesses Elevate Conversational Customer Experience Through the World’s Most Popular Messaging Apps6.2.2023 13:00:00 CET | Press release
Powered by the Freshworks Neo platform, the Freshworks CX and CRM integrations with WhatsApp, Instagram Messaging, and Facebook Messenger, enable teams to deliver intelligent and personalized messages at scale SAN MATEO, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) today announced that companies around the world have increased customer retention by using Freshworks’ conversational AI bots to automate communication with buyers through WhatsApp, Instagram Messaging, and Facebook Messenger. International companies like MTN Cameroon in Africa, Body & Fit in Europe and The Giving Movement in Dubai have elevated their customer support efficiency on Meta’s messaging platforms using Freshworks’ Freshchat™, Freshdesk™ and Freshsales™ products. With over two billion daily active WhatsApp users, nearly two billion daily active Facebook users, and more than two billion monthly active Instagram users, Meta provides the world’s most popular messaging platforms. The Meta B
Online Retailer Das Kostümland Deploys Descartes’ Ecommerce Warehouse Management Solution to Strengthen Peak Season Fulfillment6.2.2023 12:45:00 CET | Press release
MUNICH, Germany and ATLANTA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX: DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Das Kostümland, a leading German vendor of costumes and disguises, has deployed Descartes’ ecommerce warehouse management system (WMS) to keep pace with dramatic order volume seasonal spikes. The Descartes solution streamlines and accelerates the retailer’s fulfillment processes, increasing operational efficiency, reducing costs, and enhancing the customer experience. “We have more than 10,000 SKUs and, during seasonal peaks such as Halloween, we process upwards of 2,000 orders per day,” said Daria May, founder and CEO of Das Kostümland. “With Descartes’ barcode-based pick and pack processes, we’ve increased our warehouse productivity to handle even extreme seasonal order fluctuations without hiring additional labor. By optimizing our fulfillment processes, we’ve reduced picking errors,
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression6.2.2023 12:30:00 CET | Press release
Zuranolone is being evaluated as a potential 14-day, rapid-acting, once-daily, oral medication to treat major depressive disorder (MDD) and postpartum depression (PPD) Depression is a public health issue with significant unmet medical need CAMBRIDGE, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced the U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD. The application has been granted priority review and the FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of August 5, 2023. “We see potential for zuranolone, if approved, to be a meaningful new option that can help address the serious unmet need faced by the diverse pop